Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Lung cancer stands as the primary cause of cancer-related fatalities in both the United States and across the globe. The World Health Organization underscores its prevalence as the most commonly diagnosed cancer, witnessing approximately 2.09 million new cases annually. Tragically, it also claims the highest number of cancer-related deaths, accounting for approximately 1.76 million lives lost worldwide each year.
The alarming surge of lung cancer cases and mortality rates in China has intensified the gravity of the situation, marking it as a predominant cause of death since 2010. This rise has positioned cancer as a significant public health concern on a global scale. Recently, the National Central Cancer Registry of China has provided high-quality data derived from population-based registries, offering a comprehensive insight into the nation's health landscape. Disturbingly, nearly 22% of all new global lung cancer cases and close to 27% of cancer-related deaths occur within China. A noteworthy aspect is that the profile of lung cancer in China varies significantly from that observed in developed nations.
The escalating prevalence of lung cancer in recent years has prompted numerous companies to dedicate their efforts to the development of advanced pulmonary function testing devices. The primary objective behind these endeavors is to mitigate the occurrence and impact of lung cancer. This pursuit aims to revolutionize the diagnostics and detection methodologies, aiming for early identification and intervention, thereby potentially reducing the growing burden of lung cancer cases worldwide.
The burgeoning prevalence of lung cancer in various parts of the world, especially in China, has led to heightened concerns among global healthcare authorities and organizations. Despite significant advancements in medical research and technology, lung cancer remains a formidable challenge due to its complex nature and varied presentations across different regions and populations.
China's evolving healthcare landscape, coupled with its increasing lung cancer rates, has brought forth critical data from population-based cancer registries. These insights have shed light on the severity of the situation, revealing that a substantial portion of global lung cancer diagnoses and fatalities are concentrated within China's borders. The distinctive profile of lung cancer observed in China, distinct from patterns found in more developed nations, emphasizes the need for tailored strategies and interventions to address this concerning health crisis.
In response to the escalating prevalence of lung cancer, several healthcare and medical technology companies have intensified their research and development efforts. The objective is to innovate and introduce sophisticated pulmonary function testing devices capable of early detection, accurate diagnosis, and precise monitoring of lung cancer. These initiatives aim to significantly impact the way lung cancer is diagnosed and managed, ultimately striving to reduce the disease's prevalence and mortality rates.
Moreover, this surge in innovative medical devices aims not only to detect lung cancer at its early stages but also to enhance treatment modalities and improve patient outcomes. By providing healthcare professionals with advanced tools and technologies, the goal is to offer personalized and targeted therapies to individuals diagnosed with lung cancer, thus potentially enhancing their quality of life and prognosis.
The focus on developing cutting-edge pulmonary function testing devices underscores the urgency and significance of combating lung cancer. These advancements seek to equip healthcare providers and patients alike with better tools and strategies to confront the challenges posed by this prevalent and life-threatening disease.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Segment Outlook | Type, Component, Application |
Pulmonary Function Testing Systems Market Highlights:
Pulmonary Function Testing Market Analysis
The Pulmonary Function Testing Market is expected to reach USD 0.21 billion by 2032 at 4.1% CAGR during the forecast period 2023-2032. Our lungs perform the pulmonary function. This includes inhaling the air by the nasal passage that travels to the lungs, and absorbing oxygen in the blood which is carried to other parts of the body, and exhaling the carbon dioxide as a waste product through the nasal passage. Several tests are being conducted on people to check how efficiently their lungs are functioning. These are performed with the help of pulmonary function testing equipment, pulmonary function testing machine. The tests can be performed for two reasons. Firstly, if there is some blockage or obstruction in the breathing passage. Secondly, if there is some restrain or reduction in the absorption of oxygen by the blood.
Covid19 Analysis
Coronavirus is a highly infectious disease that is majorly attacking the respiratory system of people. One of the most common symptoms observed in the people affected by the SARS-Cov2 virus is difficulty in breathing and lowering of oxygen level in the body. The pulmonary function testing market saw a boom throughout the last year because pulmonary function equipment is used to detect the level of infection in the lungs of a patient.
People across the globe are suffering from the covid19. More ventilators, testing kits, and oxygen cylinders are required than they were demanded on the normal days before the global pandemic. The government of every nation is procuring and manufacturing more mobile pulmonary function testing devices which are rapid as well as require less human contact. This has surely given a hike to market  for pulmonary function testing share.
Pulmonary Function Testing Market Dynamics
Drivers
The rise in the cases of pneumonia, lung cancer, asthma, and other respiration-related problems has increased the lung function test market size. The widespread highly infectious diseases, rise in air pollution which leads to breathing problems, and drinking and smoking habits that cause lung cancer, are the primary factors that are increasing the demand for pulmonary function equipment. Pulmonary function testing to diagnose asthma holds the greatest market share.
Opportunities
The life expectancy has increased several folds which means that there is a large population of elderly people who are to be medically treated. Diseases such as lung cancer, blockage in the lungs, and asthma are more common in old-aged people. It proves to be an opportunity for the pulmonary function testing market. The awareness among people also increases the demand for portable pulmonary function testing equipment, as they can be easily used in home healthcare.
Restraints
Businesses have to abide by the law of the land and cannot operate outside it. The rigid policies of medical authorities to provide standardized pulmonary function testing devices may hinder the growth of the market globally. The raw material for manufacturing or assembling the testing equipment is expensive. This is another obstacle for the manufacturers of pulmonary function testing devices.
Value Chain Analysis
Owing to an unhealthy lifestyle and deteriorating environment, respiratory therapist pulmonary function testing arises. National Central Cancer Registry of China has reported through research conducted that near about 22% of total lung cancer cases from across the globe are from china, and globally, almost 27% of death related to respiratory problems are also reported in china.
The key players of this market globally are striving voluntarily to produce such devices and equipment which are easy to use, portable in nature, and can give concrete results. This is possible with technological advancements.
Pulmonary Function Testing Market Segmentation
The pulmonary function testing market can be divided into various segments. These are: based on type, based on test type, based on component, based on application, and based on end-users.
Based on type
- Among the different types of pulmonary function testing devices available in the market globally are complete PFT systems. These are restricted to a specific area. The portable PFT systems are easy to carry and can be used at any place.
Based on test type
- Various tests which are conducted to detect respiratory infections are Spirometer, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, High Altitude Simulation Testing.
Based on application
- These tests help detect various lung-related diseases. These are as follows: Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, and others.
Based on component
- The component used to run the pulmonary function testing devices are hardware, software, and the services which will be finally rendered to the patients.
Based on end-users
- Pulmonary function testing is done at diagnostics centers and hospitals. Research laboratories and other academic institutions also contribute a large share to the market. Child specialist hospitals are also end-user.
Pulmonary Function Testing Market Regional Analysis
Pulmonary function testing market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions where they are operating include America, Europe, Asia-pacific, and the rest of the world.
America, which includes the area of North America (the US and Canada) and Latin America, is overshadowing all the other regions. The rise in the percentage of the elderly population, larger investments in medical infrastructure by the authorities, and awareness among the general public related to respiratory diseases are the key driving factors.
The European region which includes Germany, UK, France, Russia, and Italy, has bagged the position of second-largest market share in the pulmonary function testing market globally. Unhealthy lifestyles, rise in the cases of asthma, and other respiratory diseases become the major reason for this.
Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for pulmonary function testing. It owns to the fact that the government of these countries is investing a large share of their resources in developing a robust medical infrastructure. South Korea alone accounted for the market share of 10.1% in the year 2017.
The rest of the world, which includes the region of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public.
Pulmonary Function Testing Market Competitive Landscape
The list of major key players involved in pulmonary function testing data analysis is as follows:
- COSMED Srl
- Vyaire Medical, Inc
- Medical Equipment Europe GmbH
- Medical Electronic Construction
- ECO MEDICS AG
- CHEST M.I., Inc
- MGC Diagnostic Corporation
- Medical Technologies.
-
Schiller AG - Hocoma
- NSPIRE HEALTH INC.
- ndd Medizintechnik AG
- Morgan Scientific Inc.
- Ganshorn Medizin Electronic
- Minato Holdings Inc.
- Koninklijke Philips N.V.
- Omron Healthcare, Inc.
The above-listed come together in the joint venture, mergers and, acquisitions to launching new devices. Their main objective is to deliver devices that are cost-effective, hassle-free in operations, and give concrete results. With advanced technologies, the key players are focusing on developing portable pulmonary function testing devices.
Recent Developments
Various developments that are found in pulmonary function testing Indusrty research are as follows:
- In the November of the year 2018, Auris Health fills out its investment in the portfolio of pulmonary market function. They are expecting to launch an artificial intelligence robot that will help people with medical ailments.
- In January of the year 2018, the UK-based organization, namely, Owlstone Medical, invested a huge amount in producing a respiratory cancer testing device.
- In September of the year 2016, Schiller AG threw into orbit their device called touch 7. It was more efficient in detecting the problems in pulmonary functioning.
- In the year 2017, Vyaire Medical, Inc. formed an acquisition over Revolutionary Medical Devices, Inc. they manufacture products for smoothing the functioning of air passage inside the human body.
- In March of the year 2018, COSMED Srl launched altogether new catalogue of products for monitoring and screening of pulmonary function testing.
Report Overview
This market research report of pulmonary function testing market includes the following elements:
- Market Overview
- COVID19 Analysis
- Market Dynamics
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Landscape
- Recent Developments
This research report includes the basic meaning of pulmonary function and how it works. Several tests are being conducted on people to check how efficiently their lungs are functioning. The tests are performed if there is some blockage or obstruction in the breathing passage or if there is some restrain or reduction in the absorption of oxygen by the blood. The most common symptoms observed in the people affected by the SARS-Cov2 virus are difficulty in breathing and lowering of oxygen level in the body. This has increased the market capacity for pulmonary function testing market procedures.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
